Thomson Reuters 2015 World’s Most Influential Scientific Minds Includes Fourteen MSK Researchers

Posted on by

Thomson Reuters announced their 2015 list of the World’s Most Influential Scientific Minds. How they create this list is based on several factors summarized below:

“The some 3,000 highly cited researchers listed in this report were selected by analyzing citation data over a recent 11-year period (2003-2013) and identifying those who published the greatest number of highly cited papers. We also identified hot researchers, authors of papers published in a recent two-year period (2013-2014) that were cited immediately after publication at extraordinarily high levels. Highly cited papers rank in the top 1% and hot papers rank in the top 0.1% of the citation distributions of comparable papers, those matched for field and age.”

Thomson Reuters’ list includes the following fourteen MSK researchers:

  • Jose Baselga, MD, PhD – Medical Oncologist, Physician-in-Chief and Chief Medical Officer, Memorial Hospital
  • Frederic Geissmann, MD, PhD – Researcher, William E. Snee Chair of Immunology, Sloan Kettering Institute
  • Clifford A Hudis, MD – Medical Oncologist, Vice President for Government Relations and Chief Advocacy Officer; Chief, Breast Medicine Service
  • Mark G Kris, MD – Medical Oncologist, William and Joy Ruane Chair in Thoracic Oncology
  • Marc Ladanyi, MD – Molecular Geneticist, Chief, Molecular Diagnostics Service; William J. Ruane Chair in Molecular Oncology
  • Joan Massagué, PhD – Researcher, Director, Sloan Kettering Institute
  • Gregory J Riely, MD, PhD – Medical Oncologist, Vice Chair, Clinical Trials Office, Department of Medicine
  • Alexander Y Rudensky, PhD – Chair, Immunology Program, Sloan Kettering Institute; Director, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering
  • Chris Sander, PhD – Program Chairman and Director, Computational Biology Center, Sloan Kettering Institute
  • Charles L Sawyers, MD – Internist and Hematologic Oncologist, Chair, Human Oncology and Pathogenesis Program; Marie-Josee and Henry R. Kravis Chair
  • Howard I Scher, MD – Medical Oncologist, Chief, Genitourinary Oncology Service; D. Wayne Calloway Chair in Urologic Oncology
  • Martin S Tallman, MD – Hematologic Oncologist, Chief, Leukemia Service
  • Craig B Thompson, MD – President and CEO, Memorial Sloan Kettering Cancer Center
  • William D Travis, MD – Pathologist, Director, Thoracic Pathology